Ariz. Admin. Code § 9-6-201
Current through Register Vol. 30, No. 50, December 13, 2024
Section R9-6-201 - DefinitionsIn this Article, unless otherwise specified:
1. "Clinical laboratory" has the same meaning as in A.R.S. § 36-451.2. "Drug" has the same meaning as in A.R.S. § 32-1901.3. "Epidemiologic curve" means a graphic display of the number of cases over time.4. "Normally sterile site" means an anatomic location, or tissue or body fluid from an anatomic location, in which microorganisms are not found in the absence of disease and includes: a. The lower respiratory tract;l. Another anatomic location other than the skin, mouth, eyes, upper respiratory tract, middle ear, urogenital tract, or gastrointestinal tract.5. "Health care provider required to report" means a physician, physician assistant, registered nurse practitioner, or dentist who diagnoses, treats, or detects a case or suspect case of a communicable disease listed in Table 2.1 or detects an occurrence listed in Table 2.1.6. "Pharmacist" has the same meaning as in A.R.S. § 32-1901.7. "Point of contact" means an individual through whom the Department or a local health agency can obtain information upon request.8. "Whole blood" means human blood from which plasma, erythrocytes, leukocytes, and thrombocytes have not been separated.Ariz. Admin. Code § R9-6-201
Former Section R9-6-211 renumbered and amended and subsection (C) renumbered from R9-6-212 and amended effective May 2, 1991 (Supp. 91-2). Former Section R9-6-201 renumbered to R9-6-501, new Section R9-6-201 renumbered from R9-6-601, repealed, and a new Section R9-6-201 adopted effective October 19, 1993 (Supp. 93-4). Former R9-6-201 repealed; new R9-6-201 renumbered from R9-6-102and amended by final rulemaking at 10 A.A.R. 3559, effective October 2, 2004 (Supp. 04-3). Amended by final rulemaking at 14 A.A.R. 1502, effective April 1, 2008 (Supp. 08-2). Amended by final rulemaking at 23 A.A.R. 2605, effective 1/1/2018.